Pharma & Biotech
Cardiol Therapeutics is commercializing its THC-free cannabidiol formulation to treat heart disease
Acasti Pharma eyeing FDA meeting as it continues to advance heart disease candidate CaPre
ImmunoPrecise Antibodies is expanding its therapeutic offerings as a global full-service antibody provider
Only registered members can use this feature.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.